Showing 61 - 80 results of 5,224 for search '(((( b largest decrease ) OR ( ((b large) OR (via large)) decrease ))) OR ( ai larger increases ))', query time: 1.84s Refine Results
  1. 61
  2. 62

    Supplementary Material for: Tea Consumption Is Associated with Decreased Disease Activity of Rheumatoid Arthritis in a Real-World, Large-Scale Study by Jin J. (3859486)

    Published 2020
    “…<b><i>Objectives:</i></b> The aim of this study was to explore the possible association of tea consumption with RA through a large-scale, real-world study. …”
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71

    Adaptation via altruistic mutations for all <i>k</i>. by Hanna Isaksson (747571)

    Published 2023
    “…In life cycles with higher <i>k</i>, mutations spread for a smaller range of parameters, and the range decreases as the environment changes from <i>E</i><sub><i>B</i></sub> to <i>E</i><sub><i>C</i></sub>.…”
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77

    Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma by Marijana Nesic (8771654)

    Published 2020
    “…It plays a crucial role in controlling the initiation and progression of hematologic cancers such as leukemia and lymphoma, and it has been reported that diffuse large B-cell lymphoma (DLBCL) fails to express specific cell-surface molecules that are necessary for the recognition and elimination of tumor cells.…”
  18. 78

    Image_1_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.jpeg by Shengling Ma (9119243)

    Published 2020
    “…<p>Background: Primary bone B-cell lymphoma (PB-DLBCL) is a rare entity for which existing data is limited. …”
  19. 79

    Image_2_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.tif by Shengling Ma (9119243)

    Published 2020
    “…<p>Background: Primary bone B-cell lymphoma (PB-DLBCL) is a rare entity for which existing data is limited. …”
  20. 80